Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Neurosci ; 48(5): 2165-2181, 2018 09.
Article in English | MEDLINE | ID: mdl-30144326

ABSTRACT

Acetylcholine (ACh) is involved in the modulation of the inflammatory response. ACh levels are regulated by its synthesizing enzyme, choline acetyltransferase (ChAT), and by its hydrolyzing enzymes, mainly acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). A more comprehensive understanding of the cholinergic system in experimental autoimmune encephalomyelitis (EAE) disease progression could pave the path for the development of therapies to ameliorate multiple sclerosis (MS). In this work, we analyzed possible alterations of the CNS cholinergic system in the neuroinflammation process by using a MOG-induced EAE mice model. MOG- and vehicle-treated animals were studied at acute and remitting phases. We examined neuropathology and analyzed mRNA expression of ChAT, AChE and the α7 subunit of the nicotinic acetylcholine receptor (α7nAChR), as well as AChE and BuChE enzyme activities, in brain and spinal cord sections during disease progression. The mRNA expression and enzyme activities of these cholinergic markers were up- or down-regulated in many cholinergic areas and other brain areas of EAE mice in the acute and remitting phases of the disease. BuChE was present in a higher proportion of astroglia and microglia/macrophage cells in the EAE remitting group. The observed changes in cholinergic markers expression and cellular localization in the CNS during EAE disease progression suggests their potential involvement in the development of the neuroinflammatory process and may lay the ground to consider cholinergic system components as putative anti-inflammatory therapeutic targets for MS.


Subject(s)
Brain/metabolism , Choline O-Acetyltransferase/metabolism , Cholinergic Agents/pharmacology , Encephalomyelitis, Autoimmune, Experimental/metabolism , Acetylcholine/metabolism , Acute Disease , Animals , Astrocytes/metabolism , Brain/drug effects , Choline O-Acetyltransferase/drug effects , Disease Models, Animal , Disease Progression , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Female , Macrophages/metabolism , Mice, Inbred C57BL , Microglia/metabolism , Multiple Sclerosis/chemically induced , Multiple Sclerosis/metabolism , Time Factors
2.
Cancer Lett ; 405: 79-89, 2017 10 01.
Article in English | MEDLINE | ID: mdl-28757417

ABSTRACT

MicroRNAs (miRNAs) are small non-coding RNAs that regulate many human genes including those involved in normal B-cell development. When these miRNAs are aberrantly expressed in B-cells they play key pathogenetic roles in the development and maintenance of B-cell lymphomas and by association may serve as useful biomarkers. In this review, we provide an overview of the importance of miRNAs to B-cell lymphomagenesis, as well as considering their use as biomarkers, and their potential usefulness for the clinic.


Subject(s)
Biomarkers, Tumor , Gene Expression Regulation, Neoplastic , Lymphoma, B-Cell/diagnosis , Lymphoma, B-Cell/genetics , MicroRNAs , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Humans , Lymphoma, B-Cell/pathology , MicroRNAs/genetics , MicroRNAs/metabolism
3.
Cent Nerv Syst Agents Med Chem ; 17(2): 109-115, 2017.
Article in English | MEDLINE | ID: mdl-27550615

ABSTRACT

BACKGROUND: Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease of the central nervous system (CNS) characterized by leucocytes infiltration, demyelination, axonal degeneration and neuronal death. Although the etiology of MS is still unkwon, inflammation and autoimmunity are considered to be key players of the disease. Nervous System: The severe alterations affecting the nervous system contribute to the motor and cognitive disabilities and are in large part dependent on severe inflammatory processes active in both central nervous system and immune system. Acetylcholine (ACh) appears to be involved in the modulation of central and peripheral inflammation. Immune cells as well as astrocytes and microglia respond to ACh stimuli by activation of cholinergic receptors. Muscarinic and nicotinic receptors differently contribute to the modulation of immunological and inflammatory processes stimulating pro- and anti-inflammatory cytokines respectively. The role played by ACh in MS is not yet fully understood, although some results point to its involvement in different neurological disorders such as Alzheimer's disease and schizophrenia. CONCLUSION: In the present review we summarize the evidence indicating the correlation between nervous system dysfunction in MS, with inflammation and cholinergic system alterations. Experiments performed in MS animal models and analyses on biological fluids from MS patients such as blood, serum and cerebrospinal fluid suggest that cholinergic alterations may contribute to the dysregulated inflammatory processes of MS. Many current therapeutic approaches in MS are based on anti-inflammatory drugs. We also discuss how the use of cholinesterase inhibitors or ACh mimetics may represent a new interesting therapeutic approach in MS.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Cholinergic Agents/therapeutic use , Cholinesterase Inhibitors/therapeutic use , Inflammation Mediators/metabolism , Multiple Sclerosis/metabolism , Animals , Anti-Inflammatory Agents/pharmacology , Cholinergic Agents/pharmacology , Cholinesterase Inhibitors/pharmacology , Humans , Inflammation/drug therapy , Inflammation/immunology , Inflammation/metabolism , Inflammation Mediators/antagonists & inhibitors , Multiple Sclerosis/drug therapy , Multiple Sclerosis/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...